JMJD2A-dependent silencing of Sp1 in advanced breast cancer promotes metastasis by downregulation of DIRAS3. (Q38959379)

8 September 2017

title

JMJD2A-dependent silencing of Sp1 in advanced breast cancer promotes metastasis by downregulation of DIRAS3. (English)

1 reference

8 September 2017

Liliang Li

1 reference

8 September 2017

Pan Gao

1 reference

8 September 2017

Yuhua Li

1 reference

8 September 2017

Yiwen Shen

1 reference

8 September 2017

Jianhui Xie

1 reference

8 September 2017

Daming Sun

1 reference

8 September 2017

Aimin Xue

1 reference

8 September 2017

Ziqin Zhao

1 reference

8 September 2017

Zude Xu

1 reference

8 September 2017

Mingchang Zhang

1 reference

8 September 2017

Beixu Li

1 reference

8 September 2017

Jieqing Jiang

1 reference

8 September 2017

language of work or name

English

0 references

publication date

6 September 2014

1 reference

Breast Cancer Research and Treatment

8 September 2017

published in

1 reference

8 September 2017

volume

147

1 reference

8 September 2017

1 reference

8 September 2017

page(s)

487-500

1 reference

Breast-cancer screening with trained volunteers in a rural area of Sudan: a pilot study

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3083-7

Oncogenes and tumor suppressor genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3083-7

The role of Sp1 and Sp3 in normal and cancer cell biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3083-7

Isolation of cDNA encoding transcription factor Sp1 and functional analysis of the DNA binding domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3083-7

A possible gene silencing mechanism: hypermethylation of the Keap1 promoter abrogates binding of the transcription factor Sp1 in lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3083-7

Sp1 expression regulates lung tumor progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3083-7

The oncoprotein HBXIP activates transcriptional coregulatory protein LMO4 via Sp1 to promote proliferation of breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3083-7

Triptolide-induced cell death in pancreatic cancer is mediated by O-GlcNAc modification of transcription factor Sp1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3083-7

Sp1 and krüppel-like factor family of transcription factors in cell growth regulation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3083-7

Prostaglandin E2 stimulates human lung carcinoma cell growth through induction of integrin-linked kinase: the involvement of EP4 and Sp1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3083-7

Transcriptional regulation of KiSS-1 gene expression in metastatic melanoma by specificity protein-1 and its coactivator DRIP-130.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3083-7

Differential regulation of GPR54 transcription by specificity protein-1 and partial estrogen response element in mouse pituitary cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3083-7

Role for transcription factor TFII-I in the suppression of SSeCKS/Gravin/Akap12 transcription by Src.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3083-7

Metastasis tumor-associated protein 2 enhances metastatic behavior and is associated with poor outcomes in estrogen receptor-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3083-7

On oncogenes and tumor suppressor genes in the mammary gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3083-7

NOEY2 (ARHI), an imprinted putative tumor suppressor gene in ovarian and breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3083-7

Effects of ARHI on breast cancer cell biological behavior regulated by microRNA-221.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3083-7

The tumour suppressor DiRas3 interacts with C-RAF and downregulates MEK activity to restrict cell migration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3083-7

Multiple histone deacetylases repress tumor suppressor gene ARHI in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3083-7

Genomic structure and promoter characterization of an imprinted tumor suppressor gene ARHI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3083-7

Sp transcription factor family and its role in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3083-7

HSF1 and Sp1 regulate FUT4 gene expression and cell proliferation in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3083-7

The tumor-suppressor gene ARHI (DIRAS3) suppresses ovarian cancer cell migration through inhibition of the Stat3 and FAK/Rho signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3083-7

JMJD2A contributes to breast cancer progression through transcriptional repression of the tumor suppressor ARHI

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3083-7

Cloning and characterization of the 5'-flanking region of the human transcription factor Sp1 gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3083-7

Functional characterization of JMJD2A, a histone deacetylase- and retinoblastoma-binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3083-7

Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3083-7

Transforming growth factor-beta1 induces tissue inhibitor of metalloproteinase-1 expression via activation of extracellular signal-regulated kinase and Sp1 in human fibrosarcoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3083-7

The transcriptional repressor JHDM3A demethylates trimethyl histone H3 lysine 9 and lysine 36.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3083-7

Recognition of histone H3 lysine-4 methylation by the double tudor domain of JMJD2A

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3083-7

Distinct binding modes specify the recognition of methylated histones H3K4 and H4K20 by JMJD2A-tudor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3083-7

JMJD2A promotes cellular transformation by blocking cellular senescence through transcriptional repression of the tumor suppressor CHD5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3083-7

JMJD2A is a novel N-CoR-interacting protein and is involved in repression of the human transcription factor achaete scute-like homologue 2 (ASCL2/Hash2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3083-7

The dermatomyositis-specific autoantigen Mi2 is a component of a complex containing histone deacetylase and nucleosome remodeling activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3083-7

10.1007/S10549-014-3083-7

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

8 September 2017

1047425922

0 references

1 reference